555P Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D) in advanced solid tumours (AST): Dose finding results

Authors :: F. Legrand
A. Bruno
T. de La Motte Rouge
A. Gonçalves
Claire Cropet
A. Hervieu
Nicolas Isambert
Source :: Annals of Oncology. 31:S480
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
Dose finding
medicine.medical_specialty
Durvalumab
business.industry
Internal medicine
medicine
Hematology
Vinorelbine
business
Tremelimumab
medicine.drug

Tools